Abstract
The widespread use of percutaneous angioplasty for venous stenoses has lengthened the functional life span of hemodialysis access, while preserving precious venous capital. A subset of dialysis patients with dysfunctional access sites will harbor stenoses which are intractable, in that they fail to respond to conventional balloon angioplasty or recur in the weeks following angioplasty. This editorial discusses various endovascular approaches to the management of intractable venous stenosis as well as promising future therapies.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
